A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
In combination with aspirin, omega-3 fatty acids could help treat coronary artery disease. Consult your health care provider about whether this combination would be appropriate for you if you have coronary artery disease.
Omega-3 fatty acids may reduce some of the side effects associated with cyclosporine therapy, which is often used to lower the chances of rejection in transplant recipients. Consult your health care provider before adding any new herbs or supplements to your existing medication regimen.
In an animal study, omega-3 fatty acids protected the stomach against ulcers induced by reserpine and nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin. Consult your health care provider before using omega-3 fatty acids if you are currently taking these medications.
EPA has also been shown to boost the effects of a combination of low-dose etretinate and a topical corticosteroid medication used to treat severe, chronic psoriasis. Consult your health care provider to determine if this combination therapy may be of benefit for you if you suffer from chronic psoriasis.
Eicosapentaenoic Acid (EPA); EPA
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885